Business
DKSH expands into Middle East with $390 million healthcare acquisition
Swiss trading group DKSH is buying Dubai-based Newbridge Pharmaceuticals for $390 million, expanding its healthcare business into the Middle East and North Africa. Newbridge distributes specialist medicines in 14 markets, including Saudi Arabia and the United Arab Emirates.
about 21 hours ago · 1 source



















